Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-19T00:02:38.417Z Has data issue: false hasContentIssue false
  • English
  • Français

Bullous pemphigoid development during the course of breast cancer: a radiation induced or a radiation recall dermatitis?

Published online by Cambridge University Press:  25 September 2020

Mouna Ben Rejeb Open the ORCID record for Mouna Ben Rejeb [Opens in a new window] ,
Rim Moujahed ,
Alia Zehani  and
Lotfi Kochbati
Mouna Ben Rejeb*
Affiliation:
Radiation Oncology Department, Abderrahman Mami Hospital, Ariana, Tunisia Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
Rim Moujahed
Affiliation:
Radiation Oncology Department, Abderrahman Mami Hospital, Ariana, Tunisia Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
Alia Zehani
Affiliation:
Anatomic Pathology Department, La Rabta Hospital, Tunis, Tunisia Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
Lotfi Kochbati
Affiliation:
Radiation Oncology Department, Abderrahman Mami Hospital, Ariana, Tunisia Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
*
Author for correspondence: Mouna Ben Rejeb, Radiation Oncology Department, Abderrahman Mami Hospital, Route de Raoued 2080, Ariana, Tunisia. Tel: +216 94682772. E-mail: brjmouna@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Bullous pemphigoid (BP) is the most common autoimmune bullous disease, which is usually seen in older ages. Rarely, radiotherapy (RT) has been reported as a localised trigger factor for BP.

Case:

We present a case of a 64-year-old woman who underwent radical mastectomy and radiation therapy for breast cancer. Two months after the completion of RT with adjuvant Trastuzumab, a BP eruption developed in the irradiated area, spreading thereafter to other skin areas. The patient was treated with oral corticosteroids and the lesions evolved favourably.

Conclusion:

This case demonstrates a relatively benign skin reaction that could develop during the course of cancer treatment, which required co-management by oncologists, pathologists and dermatologists.

Keywords

breast cancerradiotherapybullous pemphigoidTrastuzumab
Type
Case Study
Information
Journal of Radiotherapy in Practice , Volume 21 , Issue 1 , March 2022 , pp. 144 - 146
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cuperus, E, Albregts, M, Toonstra, J. What can be expected on irradiated skin? A dermatologic focus on acute and chronic radiotherapeutic effects, treatment, and benign dermatoses. Skinmed 2015; 13 (5): 361–374.Google ScholarPubMed
Hegedus, F, Mathew, LM, Schwartz, RA. Radiation dermatitis: an overview. Int J Dermatol 2017; 56 (9): 909–914.10.1111/ijd.13371CrossRefGoogle ScholarPubMed
Aguado, L, Marquina, M, Pretel, M, Ruiz-Carrillo, G, Espana, A. Lesions of pemphigus vulgaris on irradiated skin. Clin Exp Dermatol 2009; 34 (5): e148–e150.CrossRefGoogle ScholarPubMed
Schmidt, E, Zillikens, D. Pemphigoid diseases. Lancet 2013; 381 (9863): 320–332.CrossRefGoogle ScholarPubMed
Danescu, S, Chiorean, R, Macovei, V, Sitaru, C, Baican, A. Role of physical factors in the pathogenesis of bullous pemphigoid: case report series and a comprehensive review of the published work. J Dermatol 2016; 43 (2): 134–140.CrossRefGoogle Scholar
Campa, M, Mansouri, B, Wilcox, B, Griffin, JR. Radiation-induced localized bullous pemphigoid in a patient with breast carcinoma. Dermatol Online J 2016; 22 (1): 15.CrossRefGoogle Scholar
Folliero, G, Zurlo, A, Amanti, C, Tombolini, V, Di Paola, M. Bullous pemphigoid induced by radiation therapy. Clin Oncol (R Coll Radiol) 1995; 7 (4): 266–267.CrossRefGoogle ScholarPubMed
Cabrera-Rodriguez, JJ, Munoz-Garcia, JL, Quiros Rivero, J, Ropero Carmona, F, Rios Kavadoy, Y. Radio-induced bullous pemphigoid. Clin Transl Oncol 2010; 12 (1): 66–68.CrossRefGoogle ScholarPubMed
Nguyen, T, Kwan, JM, Ahmed, AR. Relationship between radiation therapy and bullous pemphigoid. Dermatology 2014; 229 (2): 88–96.CrossRefGoogle ScholarPubMed
Mul, VE, van Geest, AJ, Pijls-Johannesma, MC et al. Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect. Radiother Oncol 2007; 82 (1): 5–9.CrossRefGoogle ScholarPubMed
Joly, P, Roujeau, JC, Benichou, J et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002; 346 (5): 321–327.CrossRefGoogle ScholarPubMed
Lopez, AT, Khanna, T, Antonov, N, Audrey-Bayan, C, Geskin, L. A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors. Int J Dermatol 2018; 57 (6): 664–669.CrossRefGoogle ScholarPubMed
Chung, C, Stuart, D, Keyes, M. Radiation recall reaction induced by adjuvant trastuzumab (herceptin). Case Report Med 2009; 2009: 307894.CrossRefGoogle Scholar
Moon, D, Koo, JS, Suh, C-O, Yoon, CY, Bae, J, Lee, S. Radiation recall dermatitis induced by trastuzumab. Breast Cancer 2016; 23 (1): 159–163.CrossRefGoogle ScholarPubMed
Camidge, R, Price, A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001; 59(3): 237–245.10.1016/S0167-8140(01)00328-0CrossRefGoogle ScholarPubMed
Azria, D, Magné, N, Zouhair, A et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev 2005; 31 (7): 555–570.CrossRefGoogle ScholarPubMed